BDRX
Biodexa Pharmaceticals
NASDAQ: BDRX · HEALTHCARE · BIOTECHNOLOGY
$3.14
-3.09% today
Updated 2026-04-30
Market cap
$2.14M
P/E ratio
—
P/S ratio
0.58x
EPS (TTM)
$-3.38
Dividend yield
—
52W range
$3 – $97
Volume
2.5M
Biodexa Pharmaceticals (BDRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.22M | $-4.44M | $-5.46M | $-12.42M | $-13.09M | $-12.95M | $-13.45M | $-6.49M | $-9.30M | $-6.01M | $-7.05M | $-6.83M | $-12.26M | $-5.39M |
| Capital expenditures | $239000.00 | $47000.00 | $1.03M | $922000.00 | $1.35M | $707000.00 | $244000.00 | $319000.00 | $209000.00 | $320000.00 | $62000.00 | $263000.00 | $774000.00 | $1956.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $170000.00 | — | — | — | $-34000.00 | $-404000.00 | $89000.00 | $123000.00 | $28000.00 | $283000.00 | $170000.00 |
| Free cash flow | $-3.46M | $-4.48M | $-6.49M | $-13.34M | $-14.43M | $-13.66M | $-13.69M | $-6.81M | $-9.51M | $-6.33M | $-7.11M | $-7.09M | $-13.04M | $-5.40M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |